288 related articles for article (PubMed ID: 30535125)
1. FOXO1 degradation via G9a-mediated methylation promotes cell proliferation in colon cancer.
Chae YC; Kim JY; Park JW; Kim KB; Oh H; Lee KH; Seo SB
Nucleic Acids Res; 2019 Feb; 47(4):1692-1705. PubMed ID: 30535125
[TBL] [Abstract][Full Text] [Related]
2. Cinobufagin induces FOXO1-regulated apoptosis, proliferation, migration, and invasion by inhibiting G9a in non-small-cell lung cancer A549 cells.
Zhang L; Liang B; Xu H; Gong Y; Hu W; Jin Z; Wu X; Chen X; Li M; Shi L; Shi Y; Wang Y; Yang L
J Ethnopharmacol; 2022 Jun; 291():115095. PubMed ID: 35176466
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of G9a inhibitor BIX‑01294 acting on U251 glioma cells.
Guo AS; Huang YQ; Ma XD; Lin RS
Mol Med Rep; 2016 Nov; 14(5):4613-4621. PubMed ID: 27748874
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological and transcriptional inhibition of the G9a histone methyltransferase suppresses proliferation and modulates redox homeostasis in human microvascular endothelial cells.
Wojtala M; Macierzyńska-Piotrowska E; Rybaczek D; Pirola L; Balcerczyk A
Pharmacol Res; 2018 Feb; 128():252-263. PubMed ID: 29113759
[TBL] [Abstract][Full Text] [Related]
5. G9a inhibition induced PKM2 regulates autophagic responses.
Ahmad F; Dixit D; Joshi SD; Sen E
Int J Biochem Cell Biol; 2016 Sep; 78():87-95. PubMed ID: 27417236
[TBL] [Abstract][Full Text] [Related]
6. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
[TBL] [Abstract][Full Text] [Related]
7. [Inhibition of G9a attenuates cell proliferation via the mitochondrial apoptosis pathway in lung adenocarcinoma].
Wan HJ; Lyu W; Yu L; Zhou ZY; Hu YJ; Hu J
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):13-17. PubMed ID: 28104027
[No Abstract] [Full Text] [Related]
8. Histone methyltransferase G9a and H3K9 dimethylation inhibit the self-renewal of glioma cancer stem cells.
Tao H; Li H; Su Y; Feng D; Wang X; Zhang C; Ma H; Hu Q
Mol Cell Biochem; 2014 Sep; 394(1-2):23-30. PubMed ID: 24833465
[TBL] [Abstract][Full Text] [Related]
9. Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma.
Yokoyama M; Chiba T; Zen Y; Oshima M; Kusakabe Y; Noguchi Y; Yuki K; Koide S; Tara S; Saraya A; Aoyama K; Mimura N; Miyagi S; Inoue M; Wakamatsu T; Saito T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Yokosuka O; Iwama A
Oncotarget; 2017 Mar; 8(13):21315-21326. PubMed ID: 28423509
[TBL] [Abstract][Full Text] [Related]
10. BIX-01294, a G9a inhibitor, suppresses cell proliferation by inhibiting autophagic flux in nasopharyngeal carcinoma cells.
Li Q; Wang L; Ji D; Bao X; Tan G; Liang X; Deng P; Pi H; Lu Y; Chen C; He M; Zhang L; Zhou Z; Yu Z; Deng A
Invest New Drugs; 2021 Jun; 39(3):686-696. PubMed ID: 33387131
[TBL] [Abstract][Full Text] [Related]
11. Histone-lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cells.
Lu Z; Tian Y; Salwen HR; Chlenski A; Godley LA; Raj JU; Yang Q
Anticancer Drugs; 2013 Jun; 24(5):484-93. PubMed ID: 23466651
[TBL] [Abstract][Full Text] [Related]
12. G9a promotes cell proliferation and suppresses autophagy in gastric cancer by directly activating mTOR.
Yin C; Ke X; Zhang R; Hou J; Dong Z; Wang F; Zhang K; Zhong X; Yang L; Cui H
FASEB J; 2019 Dec; 33(12):14036-14050. PubMed ID: 31647887
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of H3K9 histone methyltransferase G9a attenuates renal fibrosis and retains klotho expression.
Irifuku T; Doi S; Sasaki K; Doi T; Nakashima A; Ueno T; Yamada K; Arihiro K; Kohno N; Masaki T
Kidney Int; 2016 Jan; 89(1):147-57. PubMed ID: 26444031
[TBL] [Abstract][Full Text] [Related]
14. Radiation-induced H3K9 methylation on E-cadherin promoter mediated by ROS/Snail axis : Role of G9a signaling during lung epithelial-mesenchymal transition.
Nagaraja SS; Subramanian U; Nagarajan D
Toxicol In Vitro; 2021 Feb; 70():105037. PubMed ID: 33148527
[TBL] [Abstract][Full Text] [Related]
15. G9a regulates tumorigenicity and stemness through genome-wide DNA methylation reprogramming in non-small cell lung cancer.
Pangeni RP; Yang L; Zhang K; Wang J; Li W; Guo C; Yun X; Sun T; Wang J; Raz DJ
Clin Epigenetics; 2020 Jun; 12(1):88. PubMed ID: 32552834
[TBL] [Abstract][Full Text] [Related]
16. Human EHMT2/G9a activates p53 through methylation-independent mechanism.
Rada M; Vasileva E; Lezina L; Marouco D; Antonov AV; Macip S; Melino G; Barlev NA
Oncogene; 2017 Feb; 36(7):922-932. PubMed ID: 27452519
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen species-mediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation.
Kim SY; Hong M; Heo SH; Park S; Kwon TK; Sung YH; Oh Y; Lee S; Yi GS; Kim I
Mol Carcinog; 2018 Nov; 57(11):1492-1506. PubMed ID: 29964331
[TBL] [Abstract][Full Text] [Related]
18. Menin Upregulates FOXO1 Protein Stability by Repressing Skp2-Mediated Degradation in β Cells.
Jiang Z; Xing B; Feng Z; Ma J; Ma X; Hua X
Pancreas; 2019 Feb; 48(2):267-274. PubMed ID: 30629029
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of G9a by a small molecule inhibitor, UNC0642, induces apoptosis of human bladder cancer cells.
Cao YP; Sun JY; Li MQ; Dong Y; Zhang YH; Yan J; Huang RM; Yan X
Acta Pharmacol Sin; 2019 Aug; 40(8):1076-1084. PubMed ID: 30765842
[TBL] [Abstract][Full Text] [Related]
20. Depletion of G9a gene induces cell apoptosis in human gastric carcinoma.
Lin X; Huang Y; Zou Y; Chen X; Ma X
Oncol Rep; 2016 May; 35(5):3041-9. PubMed ID: 27081761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]